Private company

NEOVASC INC

NEOVASC INC is a Canadian surgical and medical instruments and apparatus company.2 It is headquartered in Richmond, Canada.2

Last updated Oct 20, 2026.

Overview

$2.5MRevenue, fiscal 20213
-$24.9MNet income, fiscal 20213
  • IndustrySurgical & Medical Instruments & Apparatus2
  • HeadquartersRichmond, Canada2
  • Incorporated inBritish Columbia, Canada4
  • Business address2135 13700 Mayfield Place, Richmond, A1 000004
  • Filer categoryNon-accelerated filer4
  • Legal formCompany (includes community contribution company and unlimited liability company)2
  • LEI549300IWQPQMJGDOVC542
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressSuite 2600, Three Bentall Centre, V7X 1L3 Vancouver, Canada2
  • Registered withCorporations Canada, 404811-32

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

78.2%Gross margin3
-1221.2%Operating margin3
-977.0%Net margin3
30.1%Revenue growth, 20213
-47.7%Return on equity3
-$27.3MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Cost of revenue22¢$555.7K
  • Other costs75¢$1.9M
  • Income tax3¢$86.7K

Out of $2.5M in revenue.3 The company lost money this year.

Financial statements

Revenue56783$2.5M in 2021−74% since 2015
0$2.5M$5.0M$7.5M$10.0M2015: $9.9M$9.9M20152016: $9.5M$9.5M2016−4%2017: $5.4M$5.4M2017−43%2018: $1.7M$1.7M2018−68%2019: $2.1M$2.1M2019+20%2020: $2.0M$2.0M2020−6%2021: $2.5M$2.5M2021+30%
Gross profit56783$2.0M in 2021−33% since 2015
0$1.0M$2.0M$3.0M2015: $3.0M$3.0M20152016: $2.4M$2.4M2016−19%2017: $1.9M$1.9M2017−21%2018: $1.4M$1.4M2018−28%2019: $1.6M$1.6M2019+18%2020: $1.5M$1.5M2020−7%2021: $2.0M$2.0M2021+32%
Operating income56783-$31.1M in 2021+8% since 2015
-$40.0M-$30.0M-$20.0M-$10.0M02015: -$28.8M-$28.8M20152016: -$36.8M-$36.8M2016+28%2017: -$30.9M-$30.9M2017−16%2018: -$32.4M-$32.4M2018+5%2019: -$30.0M-$30.0M2019−7%2020: -$35.2M-$35.2M2020+17%2021: -$31.1M-$31.1M2021−12%
Net income56783-$24.9M in 2021−7% since 2015
-$150.0M-$100.0M-$50.0M02015: -$26.7M-$26.7M20152016: -$86.5M-$86.5M2016+224%2017: -$21.6M-$21.6M2017−75%2018: -$108.0M-$108.0M2018+399%2019: -$35.1M-$35.1M2019−67%2020: -$28.7M-$28.7M2020−18%2021: -$24.9M-$24.9M2021−13%
Fiscal year20142015201620172018201920202021
Revenue$9.9M5$9.5M6$5.4M7$1.7M8$2.1M3$2.0M3$2.5M3
Cost of revenue$555.7K3
Gross profit$3.0M5$2.4M6$1.9M7$1.4M8$1.6M3$1.5M3$2.0M3
Operating income-$28.8M5-$36.8M6-$30.9M7-$32.4M8-$30.0M3-$35.2M3-$31.1M3
Income before tax-$24.8M3
Income tax-$86.7K3
Net income-$26.7M5-$86.5M6-$21.6M7-$108.0M8-$35.1M3-$28.7M3-$24.9M3
Shares (weighted, basic)63.0M shares3

Compare NEOVASC INC with another company

Corporate structure

NEOVASC INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of NEOVASC INC

  • CVI Investments, Inc. Filed SC 13G/A on NEOVASC INC, latest Feb 14, 2022
  • NEOVASC INC Richmond, British Columbia, Canada

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What NEOVASC INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$182.0K3 Dec 31, 2021$803.3K3 Dec 31, 2020−77.3%
Operating-lease assets (leased space)$456.3K3 Dec 31, 2021$830.6K3 Dec 31, 2020−45.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$51.5M3 Dec 31, 2021$12.9M3 Dec 31, 2020+298.4%

Inventory

ItemLatestA year beforeChange
Inventory, total$1.5M3 Dec 31, 2021$839.5K3 Dec 31, 2020+76.3%

Former names

  • Medical Ventures CorpMay 8, 2007 to May 8, 20074

Timeline

  1. Apr 19, 2002Founded NEOVASC INC is founded2

Filings

67 filings to the SEC since October 2021: 1 annual reports, 1 large holders, 65 other. The latest 20:

  1. Aug 2, 2023EFFECT EDGAR
  2. Apr 24, 202315F-12B EDGAR
  3. Apr 12, 20236-K EDGAR
  4. Apr 11, 20236-K EDGAR
  5. Apr 11, 2023RW EDGAR
  6. Apr 11, 2023F-10POS EDGAR
  7. Apr 11, 2023POS AM EDGAR
  8. Apr 11, 2023S-8 POS EDGAR
  9. Apr 11, 20236-K EDGAR
  10. Mar 31, 20236-K EDGAR
  11. Mar 9, 20236-K EDGAR
  12. Mar 7, 20236-K EDGAR
  13. Feb 10, 20236-K EDGAR
  14. Feb 1, 20236-K EDGAR
  15. Jan 27, 20236-K EDGAR
  16. Jan 18, 20236-K EDGAR
  17. Jan 17, 20236-K EDGAR
  18. Jan 17, 20236-K EDGAR
  19. Nov 28, 20226-K EDGAR
  20. Nov 18, 20226-K EDGAR

The 67 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How NEOVASC INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNEOVASC INC1
  • CIK0001399708
  • Filer statusNon-accelerated filer1
  • Incorporated inBritish Columbia, Canada1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • Business address2135 13700 Mayfield place, Richmond, A1 000001
  • Phone604-270-43441
  • Shares outstanding67,654,729 as of Dec 31, 20213
  • On EDGAR sinceMay 8, 20071
  • Filings536 in all: 6-K (410), SC 13G/A (23), SC 13G (18), SUPPL (18), F-X (6), EFFECT (5), F-10 (5), 20-F (4)1
    All 35 form types

    40-F (4), F-10/A (4), UPLOAD (4), 6-K/A (3), REGDEX (3), 20FR12G/A (2), CORRESP (2), D (2), F-3 (2), S-8 (2), S-8 POS (2), SC 13D (2), 15-12G (1), 15F-12B (1), 20-F/A (1), 20FR12G (1), 25-NSE (1), 424B5 (1), 8-A12B (1), CERTNAS (1), CT ORDER (1), DEL AM (1), F-10POS (1), FWP (1), POS AM (1), RW (1), SC 13D/A (1)

  • Latest filingsAnnual report (20-F) Mar 10, 2022